PharmaBoardroom

Sherif Rashed – Managing Partner and Chairman, Magicpharma,…

Dr Sherif Rashed, managing partner and chairman of Magicpharma, explains how the company’s unique business model has allowed it to become one of the…

Chinese PD-1 Cancer Drugs: Global Competition for Big Pharma

PD-1 inhibitors have boosted survival rates for many cancer patients since their introduction in the US five years ago. Last year, MSD and BMS began…

Swedish Pharmaceutical Exports Up 27% in Q1 2019

Sweden's pharmaceutical exports shot up 27% in first quarter 2019, continuing an upward growth trend in an industry that is increasingly well-renowned…

Chinese Government Outlines Healthcare Reform Priorities

More accessible and affordable healthcare for all: China's government has outlined several proposals to expand healthcare reform in a report released…

Björn Zoëga – CEO, Karolinska University Hospital, Sweden

The Karolinska University Hospital in Stockholm is one of the largest teaching hospitals in Europe and a globally renowned healthcare institution.…

Shih-Chung Chen – Minister of Health & Welfare,…

Shih-Chung Chen, Minister of Health and Welfare of the Republic of China (Taiwan), gives an update on the Ministry’s current directives under the…

Puerto Rico’s 3-Fold Biopharma Industry Strategy

With more than 50 years of experience in pharmaceutical manufacturing, Puerto Rico is today a manufacturing base for 11 of the world’s 20 largest…

China: Indian Pharma Firms Incoming

The pharmaceutical industries of China and India, historically focused on their large domestic markets and exports to developed nations, are…

Hansoh IPO Raises $1 Billion on Hong Kong Exchange

The company sold 551 million shares in the latest IPO on the Hong Kong Exchange and plans to invest half of its earnings in R&D. Hong Kong is now…

European MidPharmas: Focused and Resilient, yet Vulnerable

European MidPharmas – R&D based pharmaceutical companies with annual revenues of between EUR 50 million and 5 billion – are having to be…

Göran A. Ando – Chairman of the Board, Novo Nordisk…

Dr Göran A. Ando, former chairman of Novo Nordisk and a Swedish life sciences industry veteran, recently moved back to his home country after over 35…

José Herraez – General Manager, Beckman Coulter Iberia

José Herraez, general manager of Beckman Coulter in Iberia, sheds light on the special features of the Danaher business model, and how that has aided…

Tagged with